This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Benefits and Risks

E. Stanton Shoemaker, MD; J. Peter Forney, MD; Paul C. MacDonald, MD

JAMA. 1977;238(14):1524-1530.

Abstract
Estrogen treatment of postmenopausal women is effective in relieving the symptoms of vasomotor instability and urogenital atrophy; estrogen treatment is effective in preventing accelerated bone loss and osteoporosis in young women following castration, but in postmenopausal women aging is a more important determinant of accelerated bone loss than is decreased estrogen secretion. Low-dose estrogen treatment of postmenopausal women neither prevents nor increases the risk of arteriosclerotic cardiovascular disease or cerebral vascular disease. It cannot be definitively established that estrogen treatment of postmenopausal women causes an increased incidence of breast tumors, but it is clear that such treatment does not prevent these tumors. It is established that estrogen treatment of postmenopausal women increases the risk ratio of endometrial carcinoma.

(JAMA 238:1524-1530, 1977)

Author Affiliations
From the Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical School, Dallas.

Footnotes
Reprint requests to Department of Obstetrics-Gynecology, The University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX 75235 (Dr MacDonald).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?